39 Although GLP-1RAs continue to be promising therapies for T2D, their long-term efficacy for weight loss after halting treatment should be further improved
Now, the medication has significantly narrowed that pipe, keeping you fuller for longer
For most patients, the question isnt which format is most pharmacologically efficient. Its which format will I actually take, every week, for months? A patient who refuses to inject themselves and skips the injection altogether gets zero benefit from semaglutides higher bioavailability
22 Pharmacists can play a pivotal role in addressing these challenges by proactively discussing medication access with patients and tailoring solutions based on individual factors such as drug type, indication, insurance coverage, and personal circumstances
Currently, the FDA has officially approved a higher-dose formulation of semaglutide called Wegovy specifically for chronic weight management in adults who are overweight or obese, even if they do not have diabetes
About insurance and cost: "Which GLP-1 is most likely to be covered under my insurance plan?" "Will your office handle the prior authorization, and how long does that typically take?" "If the first option is denied, what is the appeal process?" "Are there manufacturer savings programs or coupons available?" "Would a compounded version be an option if brand-name is too expensive?" Cost conversations are not awkward